Northern Trust’s Biofrontera BFRI Stock Holding History

Northern Trust’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,036	Closed	-$10.8K	–	4470
2023 Q2	$10.8K	Hold	1,036	–	–	﹤0.01%	4470
2023 Q1	$12.6K	Hold	1,036	–	–	﹤0.01%	4498
2022 Q4	$19K	Hold	1,036	–	–	﹤0.01%	4501
2022 Q3	$22K	Hold	1,036	–	–	﹤0.01%	4526
2022 Q2	$39K	Buy	+1,036	New	+$62.9K	﹤0.01%	4473

Other funds holding BFRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CSPIA

Cary Street Partners Investment Advisory Richmond, Virginia $494M AUM 27.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust's BFRI Position: Q3 2023 in Review

Northern Trust sold out of Biofrontera (BFRI) in Q3 2023, closing a stake of 1,036 shares — an estimated $10.8K sold.

Northern Trust first reported a position in BFRI in Q2 2022 and held it in 5 quarters. The position peaked at $39K in Q2 2022. 8 funds tracked by Wall St. Rank hold BFRI as of Q3 2023.

Northern Trust reported no remaining Biofrontera position as of Q3 2023 after selling out during the quarter.
Northern Trust sold 1,036 Biofrontera shares in Q3 2023, an estimated $10.8K.
Northern Trust first reported a position in Biofrontera in Q2 2022 and held it in 5 quarters.
Northern Trust's Biofrontera position peaked at $39K in Q2 2022.
8 funds tracked by Wall St. Rank held Biofrontera as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.